期刊文献+

盐酸胍法辛缓释片含胍法辛量和释放度测定方法研究

Study on determination method of guanfacine content and releasing rate of Guanfacine Hydrochloride Sustained Release Tablets
下载PDF
导出
摘要 目的建立盐酸胍法辛缓释片含胍法辛量和释放度测定方法。方法采用高效液相色谱法,以十八烷基硅烷键合硅胶为填充剂,以磷酸盐缓冲液∶乙腈(48∶52)为流动相;在220 nm波长处检测,用外标法计算盐酸胍法辛缓释片含胍法辛量;释放度以桨法装置,以p H2.2盐酸盐缓冲液900 m L为释放介质,1、3、6、12 h时分别取样,照含量测定的色谱条件测定,用外标法计算各时间点释放量。结果样品在释放介质中和含量测定溶剂中的精密度、线性和回收率均较好。结论该法适于测定盐酸胍法辛缓释片含胍法辛量和释放度。 Objective To establish a method for determining the guanfacine content and releasing rate of Guanfacine Hydrochloride Sustained Release Tablets. Methods The high performance liquid chromatography(HPLC) was adopted with octadecylsilane bonded silica gel as a filler. The mobile phase was phosphate buffer-acetonitrile(48∶52);the detection was at the wavelength of 220 nm. The guanfacine content of Guanfacine Hydrochloride Sustained Release Tablets was calculated by using the external standard method;the releasing rate was detected by the paddle method. With 900 m L of p H2.2 hydrochloride buffer as the release medium,the samples were taken at 1,3,6,12 h,the detection was performed according to the chromatographic condition of content determination. The external standard method was used to calculate the release time at each releasing point.Results The precision,linearity and recovery rate of the detected solution in the release medium and the content determination solvent were all good. Conclusion The method is suitable for determining the guanfacine content and releasing rate of Guanfacine Hydrochloride Sustained-Release Tablets
作者 陈祖利 徐金梅 Chen Zuli Xu Jinmei(Zhongshuai Pharmaceutical Scientifw & Technological CO. ,Ltd,Zhengzhou,Henan 450001 ,China)
出处 《现代医药卫生》 2017年第3期364-366,369,共4页 Journal of Modern Medicine & Health
关键词 胍法辛/分析 迟效制剂 色谱法 高压液相 药用制剂/分析 Guanfacine/Analysis Delayed-action preparations Chromatography High pressure liquid Pharma-ceutical preparations/Analysis
  • 相关文献

参考文献6

二级参考文献46

  • 1Ostopovici-Halip L,Curpan R,Mracec M,et al.Structural determinants of the alpha.
  • 2adrenoceptor subtype selectivity[J].J Mol Graphics & Modelling,2011,29(8):1030-1038.2 Gyires K,Zadori ZS,Torok T,et al.Alpha (2)-Adrenoceptor subtypes-mediated physiological,pharmacological actions[J].Neurochem Int,2009,55(5):447-453.
  • 3Gursoy S,Ozdemir E,Bagcivan I,et al.Effects of alpha 2-adrenoceptor agonists dexmedetomidine and guanfacine on morphine analgesia and tolerance in rats[J].Upsala J Med Sci,2011,116(6):238-246.
  • 4Kulka PJ,Tryba M,Sczepanski U,et al.Does clonidine influence the hypnotic effect of propofol[J].Anaesthesist,1993,42(12):630-637.
  • 5Kamibay T,Maze M.Clinical uses of α2-adrenergic agonist[J].Anesthesiology,2000,93(5):1345-1349.
  • 6Hunt RD,Arnsten AFT,Asbell MD.An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder[J].J Am Acad Child Adolesc Psychiatry,1995,34(15):50-54.
  • 7Arnsten AF,Steere JC,Hunt RD,et al.The contribution of α2-noradrenergic mechanisms to prefrontal cortical cognitive function:potential significance for attention-deficit hyperactivity disorder[J].Arch Gen Psychiatry,1996,53(10):448-455.
  • 8Steingard R,Biederman J,Spencer T,et al.Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders[J].J Am Acad Child Adolesc Psychiatry,1993,32(8):350-353.
  • 9Singh-Curry V,Malhotra P,Farmer SF,et al.Attention deficits following ADEM ameliorated by guanfacine[J].J Neurol Neurosurgery and Psychiatry,2010,82(11):688-690.
  • 10Song,ZM,Abou-zeid O,Fang YY.α2A adrenocptors regulate phosphorylation of microtubulte-associated protein-2 in cultured cortical neurons[J].Neuroscience,2004,123(6):405-418.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部